Abstract
Background -It is possible that many deaths from pneumonia may involve the generation of inflammatory mediators and tissue damage by activated phagocytes. To test this hypothesis phagocyte function, plasma levels of interleukin 6 (IL-6), tumour necrosis factor alpha (TNFa), and soluble interleukin 2 receptor (IL-2R), disease severity, and outcome have been examined in 46 patients with community acquired pneumonia.
Methods -Polymorphonuclear leucocyte (PMNL) and monocyte function were measured daily by chemiluminescence in these patients during the first week of admission, and cytokine levels were subsequently determined by ELISA. A series of 61 healthy individuals were used as a control group for the chemiluminescence results.
Results -There was evidence of phagocyte, particularly PMNL, activation on admission in 76% of the patients. Most patients (86%) also had raised IL-2R levels on admission. IL-6 and unbound TNFc were present in 23% and 41% of patients at varying times during the course of the disease. There was little correlation between measurements of cytokine or phagocyte levels and outcome or indicators of disease severity, although this may be because of the small number of patients included in this preliminary study. Conclusions -These results are consistent with the hypothesis that activated phagocyte function and raised levels of circulating cytokines may contribute to the pathogenesis of community acquired pneumonia. There are striking similarities in this respect between pneumonia, adult respiratory distress syndrome, and sepsis. (Thorax 1994 ;49:107-1 11) Community acquired pneumonia is a considerable problem in terms of its morbidity, mortality and use of hospital resources. ' The involvement of phagocytes in pneumonia is well known. Infiltration of affected lung parenchyma by neutrophils occurs within a short time in response to infection, and is followed by an influx of monocytes. Killing of bacteria by antibiotic treatment is associated with resolution of this inflammatory response. However, some patients in whom resolution does not occur show pathological features which are similar to those seen in the adult respiratory distress syndrome (ARDS). Multiple organ failure is often present in patients with ARDS, as it is in patients with pneumonia who do not respond to treatment.
There is compelling evidence that mediator release from phagocytes is central to the endothelial cell damage which seems to be the hallmark of ARDS.9" The role of cytokines and, in particular, tumour necrosis factor alpha (TNFcx) in this process has been closely investigated in ARDS and septic shock.'0 Since phagocytes are potent producers of TNFcx, we have studied phagocyte function and circulating cytokine levels in patients with pneumonia to determine whether phagocyte function and cytokine levels are abnormal in these patients. We have recently reported preliminary results from this study, which show that many of the patients included in our study had circulating TNFcx at some point during their stay in hospital.'
Methods

PATIENTS
Forty two consecutive admissions to King's Cross Hospital, Dundee with community acquired pneumonia were included in the study. Pneumonia was defined as the presence of new shadowing on a chest radiograph in conjunction with an appropriate clinical history and examination for which no other cause was found. Informed consent was obtained from all patients and the study was approved by the Tayside Ethical Committee. The average age of the patients was 60 years with a range of 13-87 years; 30 were men. Twelve patients had evidence of chronic obstructive airways disease and some form of pre-existing lung disease was present in a total of 16 patients. Of the 42 patients included in this sample, eight had pneumococcal infection proven by culture (five blood, three sputum), one had Klebsiella (sputum), one had Staphylococcus aureus, one had influenza B, and two had mycoplasma infection proven by serological testing. The aetiological agent was not established in 30 patients due, in part, to the loss of urine samples taken for assay of pneumococcal antigen. Six patients died. The stay in hospital of those who survived varied from 1-42 days (median 11 days), excluding one patient with social problems which prevented his discharge. Thirteen patients had received treatment from their general practitioner before admission. Consent was obtained from each patient or their relatives and 20 ml blood was taken daily starting on the morning after admission; 10 ml was taken into lithium heparin anticoagulant tubes for phagocyte assays, 5 ml into EDTA tubes, and 5 ml into a plain glass tube for serum collection. A further blood sample was taken from each survivor eight weeks after discharge for both phagocyte and cytokine assays. Clinical and other parameters collected for each patient included chest radiographic appearances, temperature, respiratory rate, presence or absence of confusion, blood pressure, arterial blood gases (if appropriate), white cell count, platelet count, lymphocyte subsets, complement level, renal and liver function.
HEALTHY CONTROLS Sixty ml heparinised venous blood samples were obtained from 61 healthy volunteers aged 20-60 years (median 36 years; male:female ratio 1:0 92), the majority of whom were staff members of a local agricultural research insti- (14%) whose responses were reduced in comparison with the normal range. In those patients who had not received treatment before admission (fig 1) the PMNL chemiluminescence response to PMA conformed to two patterns over the first week: (1) a high initial value followed by a slow decline to normal levels (6/20); and (2) a low or normal initial reading followed by a gradual rise (14/20) .
Monocyte chemiluminescence responses were also raised compared with healthy controls, with high initial responses to PMA in 20 patients (48%, KS test, p < 0 05), to SOZ in 15 patients (36%, NS), and to unopsonised zymosan in 14 patients (33%, NS). However, as with PMNLs, the striking feature was the high unstimulated monocyte production of chemiluminescence by 30 (fig 2) .
RELATION BETWEEN INDIVIDUAL IMMUNOLOGICAL PARAMETERS
The relation between the laboratory measurements was difficult to assess since the timing and speed of pathogenetic events in the patients was unknown. In patients who were not treated with an antibiotic before admission to hospital, examination of the phagocyte results showed that these also tended to rise after Nrmeal treatment, and the IL-6 level rose before TNFa in three out of four patients in whom both cytokines were measured (fig 3) . ticles. Their enhanced ability to respond to non-opsonised zymosan may reflect changes in the cell membrane which promote non-specific phagocytosis.l7"
In agreement with a recent report,'9 most patients had high levels of soluble IL-2R in their plasma on admission (fig 1) , suggesting that they had substantial lymphocytemediated immune responses. Since it is usually assumed that pneumonia reflects a non-specific acute inflammatory response to infection, this finding emphasises the fact that potentially pathogen-specific immune responses are involved at an early stage.
One of the problems of studying pneumonia is that of knowing, with any degree of accuracy, when the infection started or the rate of progression of the illness. However, those patients who reached hospital without having received antibiotic treatment are a useful subgroup since they allow the effects of current treatment strategies on the host response to be evaluated. Many of those patients who were n, not treated before admission had low or nor-)n mal phagocyte chemiluminescence on admisof sion. As phagocyte chemiluminescence rises m after admission and antibiotic treatment in this ly group of patients, it seems likely that it is not or due to prior stimulation and phagocyte "fati-)d gue." It is possible, however, that either the ry more activated cells in non-treated patients vo have been sequestered in the lung and are -o therefore not present in the peripheral blood, of or that the phagocytes are being primed as a a-result of antibiotic treatment. These two s-explanations are not mutually exclusive, since il-a small proportion of activated phagocytes ia would not be detected by the phagocyte chen-miluminescence method used, which averages iw the results from 25 000 cells in each well of the Ld microtitre plate. 1).
Our 
